Opiant Pharmaceuticals, Inc. (OPNT) Financial Analysis & Valuation | Quarter Chart
Opiant Pharmaceuticals, Inc. (OPNT)
OPNTPrice: $20.65
Fair Value: 🔒
🔒score
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal;... more
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions ... more
Description
Shares
| Market Cap | $108.80M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | US | CEO | Roger Crystal |
| IPO Date | 2007-06-04 | CAGR | — |
| Employees | 37 | Website | www.opiant.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
OPNT chart loading...
Fundamentals
Technicals
| Enterprise Value | $36.37M | P/E Ratio | -3.16 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 2.67 | P/B Ratio | 1.96 |
| P/CF Ratio | 47.76 | P/FCF Ratio | 56.47 |
| EPS | $-6.53 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 431.25% | Gross Margin | 0.78% |
| Operating Margin | 0.13% | Profit Margin | 0.07% |
| ROE | 0.07% | ROA | 0.04% |
| ROCE | 0.08% | Current Ratio | 10.1 |
| Quick Ratio | 442.49 | Cash Ratio | 5.53 |
| Debt/Equity | 0.36 | Interest Coverage | 2.42 |
| Altman Z Score | 2.86 | Piotroski Score | 4 |